HealthWell: Metabolic Dysfunction-Associated Steatohepatitis

Coverage RequiredNot Funded
About
The HealthWell Foundation MASH fund provides up to $8,000 per year in copay and premium assistance for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH). Wegovy received FDA approval for MASH with liver fibrosis in August 2025, making it eligible under this fund when prescribed for MASH indication. Income must be at or below 500% of FPL.
Insurance requirements: Commercially Insured, Medicare / Medicaid
Enrollment Forms
HealthWell Online Application
Benefits
$8000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: Yes
Needs Based: Yes
Activation Required: No
Program Details
Up to $8,000 per year in copay and premium reimbursement assistance
No minimum copay or premium reimbursement amount
Wegovy is eligible when prescribed for MASH indication (FDA approved August 2025)
Income must be at or below 500% of Federal Poverty Level
Must have insurance covering the medication and receive treatment in the US
Patients must submit Diagnosis Verification form within 30 days
Grants valid for one full year; must use or reenroll
First reimbursement request must be within 90 days of approval
Grants inactive for 90+ days will be closed
onehub-banner
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Other Programs

HealthWell Foundation: MASH

Coverage Required
Commercially Insured
Medicare / Medicaid
Max Saving: $8000/year*

NovoCare Pharmacy Home Delivery

Other Tools for Wegovy
Frequently Asked Questions (FAQ)